What is "Opioid Stewardship"? An Overview of Current Definitions and Proposal for a Universally Acceptable Definition.

opioid opioid stewardship opioid stewardship definition stewardship

Journal

Journal of pain research
ISSN: 1178-7090
Titre abrégé: J Pain Res
Pays: New Zealand
ID NLM: 101540514

Informations de publication

Date de publication:
2023
Historique:
received: 09 09 2022
accepted: 19 01 2023
entrez: 17 2 2023
pubmed: 18 2 2023
medline: 18 2 2023
Statut: epublish

Résumé

Opioid stewardship has been widely used to promote rational use, monitoring and discontinuation of opioid therapy; however, its definition and scope of practice remain unclear. To synthesize definitions of opioid stewardship proposed by clinical practice guidelines and professional societies, and to offer a proposal for a universally acceptable definition. Systematic literature searches were performed (earliest records to May 2022) in six databases (MEDLINE, EMBASE, APA PsycINFO, Scopus, and CENTRAL) and grey sources guidelines development bodies and professional societies through Google. The conventional but widely applied content analysis and word frequencies were used to analyze the definitions and scope of practice. After removing duplicates, 449 articles were retrieved (439 databases and registers and 11 from other sources), 19 of which included a definition of "opioids stewardship". A total of 12 themes was identified in the definitions, including 1) improvement or appropriateness of prescribing opioids use, 2) mitigation of risk from opioids, 3) monitoring opioid use, 4) evaluation of opioid use, 5) judicious opioid use, 6) appropriateness of opioid disposal, 7) identification and treatment of opioid use disorder, 8) reduction in mortality associated with opioid overdoses, 9) appropriate procurement practices, 10) appropriate storage, 11) promoting better communications between patients and prescribers including education provision and 12) patient-centered decision-making. Opioid stewardship is inconsistently defined across professional and research literature. While there is a greater focus on appropriateness and need for improvement of prescribing and monitoring of opioid use, the importance of communications between patients and prescribers, and patient involvement in both prescribing and deprescribing decision-making remains sparse. A comprehensive definition has been proposed as part of the work. There is a need to develop and validate the proposed definition and scope of practice to promote rationale for opioid prescribing, use and attainment of favourable outcomes through international consensus involving practitioners, researchers, and patients.

Identifiants

pubmed: 36798077
doi: 10.2147/JPR.S389358
pii: 389358
pmc: PMC9926985
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

383-394

Informations de copyright

© 2023 Shrestha et al.

Déclaration de conflit d'intérêts

All authors report no conflicts of interest in this work.

Références

J Patient Saf. 2020 Sep;16(3S Suppl 1):S36-S41
pubmed: 32809999
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Jt Comm J Qual Patient Saf. 2019 Jan;45(1):1-2
pubmed: 30522832
BMJ Open. 2021 Jan 19;11(1):e044493
pubmed: 33468530
J Addict Med. 2022 Jul-Aug 01;16(4):386-388
pubmed: 34690337
J Pain Palliat Care Pharmacother. 2020 Dec;34(4):181-183
pubmed: 32757904
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
Med J Aust. 2016 May 2;204(8):315-7
pubmed: 27125806
J Am Pharm Assoc (2003). 2022 May-Jun;62(3):697-700
pubmed: 35221235
Pain Manag. 2022 May;12(4):535-555
pubmed: 35118876
Br J Anaesth. 2019 Jun;122(6):e215-e216
pubmed: 30916016
Pharmacy (Basel). 2021 Jul 01;9(3):
pubmed: 34287334
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Pain Ther. 2018 Jun;7(1):23-36
pubmed: 29623667
Anesth Analg. 2017 Nov;125(5):1667-1674
pubmed: 29049112
J Addict Med. 2017 Jul/Aug;11(4):315-319
pubmed: 28426439
Br J Anaesth. 2021 Jun;126(6):1088-1092
pubmed: 33707092
Am J Health Syst Pharm. 2020 Apr 1;77(8):636-643
pubmed: 32236455
PLoS One. 2020 May 4;15(5):e0232538
pubmed: 32365132
Hosp Pharm. 2019 Feb;54(1):57-62
pubmed: 30718936
Healthcare (Basel). 2021 Mar 16;9(3):
pubmed: 33809571
Hosp Pharm. 2019 Aug;54(4):266-273
pubmed: 31320777
Int J Clin Pharm. 2021 Apr;43(2):318-322
pubmed: 33252724
Anesth Analg. 2017 Nov;125(5):1741-1748
pubmed: 29049118
Prim Care Companion CNS Disord. 2012;14(3):
pubmed: 23106029
Mayo Clin Proc. 2015 Jun;90(6):828-42
pubmed: 26046416
Am J Emerg Med. 2020 Apr;38(4):695-701
pubmed: 31182367
BMJ Open. 2019 Apr 16;9(4):e023990
pubmed: 30992289
Lancet. 2019 Oct 26;394(10208):1560-1579
pubmed: 31657732
Can Fam Physician. 2019 May;65(5):321-330
pubmed: 31088869

Auteurs

Sunil Shrestha (S)

School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia.

Asmita Priyadarshini Khatiwada (AP)

Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.

Binaya Sapkota (B)

Department of Pharmaceutical Sciences, Nobel College, Kathmandu, Nepal.

Simit Sapkota (S)

Department of Clinical Oncology, Civil Service Hospital, Minbhawan, Kathmandu, Bagmati Province, Nepal.
Department of Clinical Oncology, Kathmandu Cancer Center, Tathali, Bagmati Province, Nepal.

Prabhat Poudel (P)

Nepal Medical College Hospital, Kathmandu, Province Bagmati, Nepal.

Bhuvan Kc (B)

College of Public Health, Medical & Veterinary Sciences, James Cook University, Townsville, QLD, Australia.
Faculty of Pharmacy and Pharmaceutical Sciences Monash University Parkville Campus Parkville, Melbourne, VIC 3052, Australia.

Siew Li Teoh (SL)

School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia.

Ali Qais Blebil (AQ)

School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Selangor, 47500, Malaysia.

Vibhu Paudyal (V)

School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

Classifications MeSH